Top Startup and Tech Funding News – May 27, 2025

It’s Tuesday, May 27, 2025. After a short pause for Memorial Day, we’re back with your daily funding rundown, tracking where the money’s moving, who’s backing bold bets, and which startups are stepping out of stealth and into the spotlight.

From AI-powered ultrasound to programmable protein degraders, today’s lineup is a snapshot of how diverse—and daring—the startup ecosystem continues to be. Whether it’s supercharging logistics with digital co-pilots or using 3D printers to make personalized medicine on demand, the ambition on display cuts across industries and continents.

Funding Highlights

Topping today’s list is GlycoEra, which raised a $130 million Series B to rewire the immune system using precision degraders. Not far behind, Exo is closing in on a $100 million raise to put AI-powered ultrasounds in doctors’ hands worldwide, drawing interest from none other than Samsung Medison. Over in logistics, Pallet locked in $27 million to build an AI workforce for freight, while SpAItial emerged from stealth with $13 million to bring “text-to-3D” world-building into reality. Meanwhile, CurifyLabs pulled in €6.7 million to scale its RoboPharma platform, making personalized drug compounding as easy as pressing print.

Investor Activity

Today’s capital stack features a mix of old guard and strategic newcomers. Heavy hitters like Novo Holdings, General Catalyst, and Earlybird Venture Capital led significant rounds, while strategic giants like Samsung Medison and national innovation funds like Business Finland made notable moves. Across biotech, construction, and dev tools, investor conviction remains strong, especially where innovation meets scalability.

These rounds highlight a cautious market, but far from quiet. In a capital environment that rewards clarity, vision, and traction, startups that solve deep-rooted problems—whether in health, logistics, or infrastructure—are still getting funded and fast-tracking the future.

Below is a full breakdown of every deal we tracked today, complete with summaries, investor context, and funding details to get you caught up quickly.

GlycoEra Raises $130 M Series B for Precision Protein Degraders in Autoimmune Disease

GlycoEra, a Swiss biotech startup focusing on protein degraders for autoimmune conditions, has raised a $130 million Series B round. The financing was led by Novo Holdings, with participation from Catalio Capital, LifeArc Ventures, Qatar Investment Authority (QIA), Sofinnova Partners, Roche Ventures, and pharmaceutical giant Bristol Myers Squibb. GlycoEra operates dual headquarters in Switzerland and Massachusetts and develops extracellular protein degrader therapies aimed at difficult-to-treat immune disorders.

The fresh capital will be used to advance GlycoEra’s lead drug candidate (an IgG4-targeted degrader) into clinical trials and to accelerate a second program into the clinic. This significant raise, which brings GlycoEra’s total funding to around $179 million to date, underscores investor enthusiasm for novel immunology approaches and the growing interest in targeted protein degradation technology.

Funding Details:

Startup: GlycoEra (Basel, Switzerland & Newton, MA – biotech for precision immunology)

Investors: Novo Holdings (lead); Catalio Capital, LifeArc Ventures, QIA, Sofinnova Partners, Roche Ventures, Bristol Myers Squibb

Amount Raised: $130 million

Total Raised: ~$179 million (including this round)

Funding Stage: Series B

Funding Date: May 27, 2025

Exo Secures ~$100 M Financing (Samsung-Backed) for AI-Powered Handheld Ultrasound

Exo, a Silicon Valley-based medical imaging startup, is finalizing a funding round of up to $100 million to expand its AI-enhanced handheld ultrasound platform, Bloomberg reported. The impending raise is said to be led by Sands Capital, Bold Capital, and Qubit Health Capital, and notably, Samsung’s medtech arm (Samsung Medison) is reportedly eyeing a major investment in the round.

Exo has already raised over $320 million from prior backers, including RA Capital, BlackRock, Intel Capital, Sony Innovation Fund, and others. Its flagship device, the Exo Iris, is a portable ultrasound probe that uses advanced AI (e.g., the SweepAI assistant) to provide real-time imaging guidance and diagnostic insights without requiring multiple bulky machines. With Samsung’s strategic support and new capital, Exo aims to scale manufacturing of its handheld ultrasounds and broaden access to point-of-care imaging, bringing affordable diagnostic tools to more clinicians worldwide.

Funding Details:

Startup: Exo (Redwood City, CA – handheld AI ultrasound devices)

Investors: Sands Capital, Bold Capital, Qubit Health (co-leads); Samsung Medison (strategic); participation from existing major investors (RA Capital, BlackRock, Intel, etc.)Amount Raised: up to $100 million (ongoing round)

Total Raised: >$320 million to date

Funding Stage: Late-stage (Series undisclosed)

Funding Date: May 27, 2025 (reported)

Pallet Raises $27 M Series B to Modernize Logistics Back-Office with AI

Pallet, a San Francisco-based logistics tech startup, announced a $27 million Series B funding round aimed at scaling its AI-driven platform for freight and shipping companies. The round was led by General Catalyst and joined by top firms Bain Capital Ventures, Activant Capital, Bessemer Venture Partners, and a roster of notable angel investors such as Dan Lewis (Convoy co-founder).

Pallet’s core product, called CoPallet, acts as an “AI workforce” for supply chain operators, automating high-volume back-office tasks like freight order entry, quoting, and shipment tracking with human-level accuracy. The influx of capital will fuel the expansion of Pallet’s product and engineering teams and help the company meet growing demand from 3PLs, freight brokers, carriers, and shippers for efficiency gains. This Series B brings Pallet’s total funding to $50 million, as it continues building a new operating system for the $11 trillion logistics industry.

Funding Details:

Startup: Pallet (San Francisco, CA – AI “co-pilot” for logistics operations)

Investors: General Catalyst (lead); Bain Capital Ventures, Activant Capital, Bessemer Venture Partners; notable angels including Dan Lewis (Convoy)

Amount Raised: $27 million

Total Raised: $50 million

Funding Stage: Series B

Funding Date: May 27, 2025

SpAItial Launches with $13 M Seed to Make 3D Creation as Simple as Text Editing

SpAItial, a Munich-based AI startup co-founded by Synthesia’s former CTO Matthias Niessner, has emerged from stealth with a $13 million seed funding round. The investment was led by Earlybird Venture Capital (an early backer of UiPath) and joined by Speedinvest, as well as high-profile angel investors like Robin Rombach (Black Forest Labs CEO) and Victor Riparbelli (CEO of Synthesia).

SpAItial is developing cutting-edge generative AI models capable of producing fully interactive, photorealistic 3D environments from simple text prompts. This leap from 2D to interactive 3D content represents a major advance beyond current image generators like DALL-E. With only a teaser demo released so far, SpAItial’s technology has already drawn significant interest. The new funds will support hiring and R&D as the company aims to enable “text-to-3D” world-building — a potential game-changer for industries from entertainment and gaming to urban planning and the metaverse.

Funding Details:

Startup: SpAItial (Munich, Germany – AI-native 3D content generation)

Investors: Earlybird VC (lead); Speedinvest; angels including Robin Rombach and Synthesia’s Victor Riparbelli

Amount Raised: $13 million

Total Raised: $13 million (seed round to date)

Funding Stage: Seed

Funding Date: May 27, 2025

CurifyLabs Grabs €6.7 M to Automate Personalized Pharmacy Care with “RoboPharma”

CurifyLabs, a Finnish healthtech startup, has secured €6.7 million (approximately $7.2 M) in funding to modernize the compounding of personalized medications. The round was led by Springvest and includes a €1 million deep-tech loan from the government organization Business Finland. This new investment brings CurifyLabs’ total funding to €17.6 million to date.

Founded in 2021, CurifyLabs aims to automate the currently slow, labor-intensive process by which pharmacies produce custom drug dosages for patients (such as children or those with rare diseases). The startup’s proprietary RoboPharma platform integrates specialized 3D printing and formulation technology to compound medicines (liquids, tablets, ointments, etc.) with greater speed, safety, and precision than manual methods.

With the fresh funds, CurifyLabs plans to ramp up operations, expand its customer base in Europe and the U.S., and commercialize its automated compounding system across high-volume pharmacy networks. The ultimate goal is to improve drug supply resilience and patient care through on-demand, personalized drug manufacturing.

Funding Details:

Startup: CurifyLabs (Helsinki, Finland – automated compounding for personalized medicine)

Investors: Springvest (lead); plus a €1 M innovation loan from Business Finland

Amount Raised: €6.7 million (~$7.2 M)

Total Raised: €17.6 million

Funding Stage: Early-stage (Series A)

Funding Date: May 27, 2025

Neuron Factory Raises $6 M Seed to Bring AI “Coworkers” to Construction Sites

Neuron Factory, a Redwood City, CA-based startup building AI software for the construction industry, has raised $6 million in seed funding. The round drew support from an array of venture investors, including Activant Capital, Colle Capital, Karman Ventures, and Punch Capital, along with strategic investor Filip Cordeel (Chairman of Cordeel Group, a large European construction firm). In conjunction with the funding, Neuron Factory announced a partnership with Cordeel Group, reflecting the deep industry ties in its approach.

Neuron Factory’s platform is described as an AI “co-worker” for construction project teams: it uses a proprietary enterprise task graph to map all tasks, roles, and knowledge in a project, enabling intelligent AI agents to assist with real-time coordination, task delegation, and decision support on job sites. By embedding AI into the complex workflows of construction, the startup aims to improve efficiency and reduce costly errors or delays. The seed capital will be used to accelerate product development and pilot deployments of Neuron Factory’s AI agents on large construction projects in both the U.S. and Europe.

Funding Details:

Startup: Neuron Factory (Redwood City, CA – AI assistant platform for construction project management)

Investors: Activant Capital, Colle Capital, Karman Ventures, Punch Capital; Filip Cordeel (Cordeel Group chairman) as strategic investor

Amount Raised: $6 million

Total Raised: $6 million (seed round)

Funding Stage: Seed

Funding Date: May 27, 2025

Bito Bites Off $5.7 M Seed to Take On GitHub Copilot in AI Code Review

San Francisco-based Bito has closed a $5.7 million seed round to expand its AI-driven code review platform. The funding was led by Vela Partners and joined by NextView Ventures, Maxitech Ventures, Eniac Ventures, and others, bringing Bito’s total financing to $8.8 million so far. Bito’s product is an AI Code Review Agent that integrates with developers’ existing workflows (GitHub, GitLab, Bitbucket, etc.) to automatically analyze new code, catch bugs, suggest fixes, and even implement certain improvements autonomously.

By offloading the burdensome code review process from human engineers, Bito aims to speed up development cycles and improve software quality, positioning itself as an upstart competitor to AI pair-programming tools like GitHub Copilot. The startup plans to use the seed money to accelerate product development and bring its AI code assistant to more developer teams, addressing what it sees as an overlooked pain point in the software lifecycle.

Funding Details:

Startup: Bito (San Francisco, CA – AI code review assistant for developers)

Investors: Vela Partners (lead); NextView Ventures, Maxitech Ventures, Eniac Ventures, and others

Amount Raised: $5.7 million

Total Raised: $8.8 million

Funding Stage: Seed

Funding Date: May 27, 2025

Contineu Raises $1.2 M Seed to Build an AI Data Backbone for Construction

Contineu, a Bengaluru, India-based deep-tech startup, has raised $1.2 million in seed funding to advance its AI-powered data infrastructure for the construction industry. The round was led by SenseAI Ventures, with participation from Piper Serica Angel Fund. Founded in 2023, Contineu addresses the chronic lack of real-time, actionable data on construction sites by using helmet-mounted cameras and 3D computer vision models to automatically capture site progress and convert it into digital data.

In essence, Contineu’s platform automates what site engineers traditionally do manually – collecting and inputting field data – thus saving hours per day and enabling richer analytics for construction project management. The startup will use the capital to expand its engineering and product teams, strengthen its AI infrastructure, and scale up enterprise deployments with large construction firms. By building a vertical AI data stack for construction, Contineu aims to bring one of the world’s largest (and least digitized) industries into the era of real-time intelligence.

Funding Details:

Startup: Contineu (Bengaluru, India – AI/Computer Vision platform for construction site data)

Investors: SenseAI Ventures (lead); Piper Serica Angel Fund

Amount Raised: $1.2 million

Total Raised: $1.2 million (pre-seed/seed to date)

Funding Stage: Seed

Funding Date: May 27, 2025

Funding Summary Table